These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173 [TBL] [Abstract][Full Text] [Related]
4. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740 [TBL] [Abstract][Full Text] [Related]
5. A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC. Jumeau R; Filion É; Bahig H; Vu T; Lambert L; Roberge D; Doucet R; Campeau MP Br J Radiol; 2017 Jul; 90(1075):20170196. PubMed ID: 28590814 [TBL] [Abstract][Full Text] [Related]
7. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry. Coroller TP; Mak RH; Lewis JH; Baldini EH; Chen AB; Colson YL; Hacker FL; Hermann G; Kozono D; Mannarino E; Molodowitch C; Wee JO; Sher DJ; Killoran JH PLoS One; 2014; 9(4):e94859. PubMed ID: 24728448 [TBL] [Abstract][Full Text] [Related]
8. Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain. Din SU; Williams EL; Jackson A; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Rimner A Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):418-24. PubMed ID: 26254680 [TBL] [Abstract][Full Text] [Related]
13. Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies. Ma JT; Liu Y; Sun L; Milano MT; Zhang SL; Huang LT; Jing W; Zhao JZ; Han CB; Kong FS Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):843-850. PubMed ID: 30496884 [TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer. Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227 [TBL] [Abstract][Full Text] [Related]
15. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes. Woody NM; Videtic GM; Stephans KL; Djemil T; Kim Y; Xia P Int J Radiat Oncol Biol Phys; 2012 May; 83(1):427-34. PubMed ID: 22197087 [TBL] [Abstract][Full Text] [Related]
16. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903 [TBL] [Abstract][Full Text] [Related]
17. Chest wall pain following lung stereotactic body radiation therapy using 48Gy in three fractions: A search for predictors. Albers J; Parker W; Kildea J; Pembroke C; Faria S Cancer Radiother; 2019 Apr; 23(2):98-103. PubMed ID: 30952561 [TBL] [Abstract][Full Text] [Related]
18. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT). Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion. Berriochoa C; Videtic GM; Woody NM; Djemil T; Zhuang T; Stephans KL Clin Lung Cancer; 2016 Nov; 17(6):595-601. PubMed ID: 27301539 [TBL] [Abstract][Full Text] [Related]
20. Correlation Between Dosimetric Parameters and Acute Dermatitis of Post-operative Radiotherapy in Breast Cancer Patients. Takenaka T; Yamazaki H; Suzuki G; Aibe N; Masui K; Shimizu D; Nishimura T; Nakashima A; Ogata T; Matsushita K; Yoshida K; Yamada K In Vivo; 2018; 32(6):1499-1504. PubMed ID: 30348708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]